Abbreviations
- m-AMSA:
-
N-[4-(9-acrydinylamino)-3-methoxy-phenyl]methanesulphonamide
- CoSAL:
-
trans-bis salicylaldoximato cobalt
- RuIm:
-
trans-imidazolium (bis imidazole) tetrachloro ruthenate
- RuInd:
-
trans-indazolium (bis indazole) tetra-chloro ruthenate
- RuSAL:
-
trans-bis salicylaldoximato ruthenium
- Topo II:
-
topoisomerase II
References
Adachi Y, Luke M and Laemmli U K 1991 Chromosome assembly in vitro: topoisomerase II is required for condensation; Cell64 137–148
Berger J M, Gamblin S J, Harrison S C and Wang J C 1996 Structure and mechanism of DNA topoisomerase II; Nature (London)379 225–232
Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding; Anal. Biochem.72 248–254
Downes C S, Clarke D J, Mullinger A M, Gimenez-Ablan J F, Greighton A M and Johnson R T 1994 Nature (London)372 467–470
Froelich-Ammon S J and Osheroff N 1995 Topoisomerase poisons: harnessing the dark side of enzyme mechanism; J. Biol. Chem.270 21429–21432
Fruhauf S and Zeller W J 1991 New platinum titanium and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells; Cancer Res.51 2943–2948
Galande S and Muniyappa K 1996 Purification and functional characterization of type II DNA topoisomerase from rat testis and comparison with topoisomerase II from liver; Biochem. Biophys. Acta1308 58–66
Jayaraju D, Vashisht Gopal Y N and Kondapi A K 1999 Topoisomerase II is a cellular target for antiproliferative cobalt salicylaldoxime; Arch. Biochem. Biophys.369 68–77
Keppler B K, Berger M R and Heim ME 1990 New tumorinhibiting metal complexes; Cancer Treat. Rev.17 261–277
Keppler B K, Henn M, Juhl U M, Berger M R, Niebl R and Wagner F F 1989 New ruthenium complexes for the treatment of cancer; Prog. Clin. Biochem. Med.10 41–69
Ni Dhubhghaill O M, Hagen W R, Keppler B K, Lipponer K-G and Sadler P J 1994 Aquation of the anticancer complex trans-[RuCl4 Him2]-Him=imidazole; J. Chem. Soc. Dalton Trans. 3305–3310
Osheroff N, Shelton E R and Brutlag DL 1983 DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA; J. Biol. Chem.258 9536–9543
Pruss G J and Drlica K 1986 Topoisomerase I mutants: the gene on pBR322 that encodes resistance to tetracycline affects plasmid DNA supercoiling; Proc. Natl. Acad. Sci. USA83 8952–8956
Vashisht Gopal Y N, Jayaraju D and Anand K Kondapi 2000 Topoisomerase II poisoning and antineoplastic action by DNA-nonbinding diacetyl and dicarboaldoxime derivatives of ferrocene; Arch. Biochem. Biophys.376 229–235
Vashisht Gopal Y N, Jayaraju D and Kondapi A K 1999 Inhibibition of topoiosmerase II catalytic activity by two ruthenium compounds: A ligand dependent mode of action; Biochemistry38 4382–88
Wang J C 1985 DNA topoisomerases; Annu. Rev. Biochem.54 665–697
Wang J C 1991 DNA Topoisomerases: Why so many?; J. Biol. Chem.266 6659–6662
Wang J C 1996 DNA topoisomerases; Annu. Rev. Biochem.65 635–692
Wang Z and Rossman T G 1994 Large-scale supercoiled plasmid preparation by acidic phenol extraction; BioTechniques16 460–463
Watt P M and Hickson I D 1994 Structure and function of type II DNA topoisomerases; Biochem. J.303 681–695
Zecheidrich E L, Christiansen K, Anni H, Westergaard O and Osheroff N 1989 Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate; Biochemistry28 6229–6236
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vashisht Gopal, Y.N., Kondapi, A.K. Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium. J Biosci 26, 271–276 (2001). https://doi.org/10.1007/BF02703651
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02703651